Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, Cristina Belén García, María Pilar Ribate
Topics & Concepts
CYP2C19Therapeutic drug monitoringClozapinePharmacologyMedicineValproic AcidPharmacokineticsConcomitantGenotypeInternal medicineTherapeutic indexCYP2D6GenotypingDrugGastroenterologyChemistryCytochrome P450Schizophrenia (object-oriented programming)EpilepsyMetabolismPsychiatryBiochemistryGenePharmacological Effects and Toxicity StudiesSchizophrenia research and treatmentBipolar Disorder and Treatment